Stay updated on Botensilimab for Advanced Melanoma Clinical Trial
Sign up to get notified when there's something new on the Botensilimab for Advanced Melanoma Clinical Trial page.

Latest updates to the Botensilimab for Advanced Melanoma Clinical Trial page
- Check2 days agoChange DetectedThe site footer now displays revision v3.8.0 instead of v3.7.2.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe advanced melanoma study was updated to terminated following a sponsor decision and is no longer seeking participants. The record also includes changes to its outcome measures.SummaryDifference2%

- Check30 days agoChange DetectedThe site footer’s revision identifier changed from v3.7.0 to v3.7.1. The study record content remains unchanged.SummaryDifference0.1%

- Check51 days agoChange DetectedA new revision entry (v3.7.0) was added to the study record history, replacing the previous revision (v3.6.6). This reflects an update to the record version rather than changes to the study content.SummaryDifference0.1%

- Check65 days agoChange DetectedThis update adds the latest revision (v3.6.6) to the study's history, indicating an updated version of the record. The previous revision (v3.6.5) is removed from the visible history list.SummaryDifference0.1%

- Check86 days agoChange DetectedA new revision entry (v3.6.5) has been added to the Study Record History, indicating the latest revision of the page’s history log.SummaryDifference0.1%

Stay in the know with updates to Botensilimab for Advanced Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Botensilimab for Advanced Melanoma Clinical Trial page.